Role of central dopaminergic receptors in manic response of cats to morphine.
D000818:Animals; D001285:Atropine / Q000494:pharmacology; D001714:Bipolar Disorder / Q000139:chemically induced*; D002415:Cats; D002490:Central Nervous System / Q000378:metabolism; D002746:Chlorpromazine / Q000494:pharmacology; D004298:Dopamine / Q000378:metabolism; D004336:Drug Antagonism; D005260:Female; D006220:Haloperidol / Q000494:pharmacology; D006634:Histamine H1 Antagonists / Q000494:pharmacology; D006801:Humans; D008238:Lysergic Acid Diethylamide / Q000494:pharmacology; D008297:Male; D009020:Morphine / Q000009:adverse effects*; D010643:Phenoxybenzamine / Q000494:pharmacology; D011433:Propranolol / Q000494:pharmacology; D011758:Pyrroles / Q000494:pharmacology; D011955:Receptors, Drug / Q000187:drug effects*; D012110:Reserpine / Q000494:pharmacology; D013747:Tetrabenazine / Q000494:pharmacology
D006634:Histamine H1 Antagonists; D011758:Pyrroles; D011955:Receptors, Drug; D010643:Phenoxybenzamine; D009020:Morphine; D001285:Atropine; D012110:Reserpine; D008238:Lysergic Acid Diethylamide; D011433:Propranolol; D006220:Haloperidol; D002746:Chlorpromazine; D004298:Dopamine; D013747:Tetrabenazine